Discovery of Novel Antibiotics, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 732
Special Issue Editor
Interests: biomarkers discovery; drugs discovery; metabolomics; FTIR spectroscopy; diagnostic; prognosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Discovery of Novel Antibiotics” was published in 2021. It is a successful collection with four excellent papers and has encouraged us to open a second edition on the same topic.
As a continuation of the first Special Issue, this second edition aims to present the current challenges and solutions in the development of novel antibiotics. Topics may include, but are not limited to, the following:
- Strategies based on medicinal chemistry;
- Semi-synthetic and synthetic products;
- Target-based drug discovery;
- Combinatorial biosynthesis;
- Screening of natural compounds;
- New screening methods;
- Novel cultivation methods for previously “unculturable” bacteria;
- Phage therapy.
Dr. Cecília R.C. Calado
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics discovery
- drugs screening
- antibiotics resistance
- antimicrobial resistance
- systems biology
- gene variant
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Discovery of Novel Antibiotics in Antibiotics (4 articles)
